South Korea Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • ID: 4342790
  • Report
  • Region: South Korea
  • 110 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • Hospira Inc
  • Medtronic plc
  • MORE
South Korea Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

The new report, "South Korea Drug Delivery Devices Market Outlook to 2023", provides key market data on the South Korea Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the South Korea Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • Hospira Inc
  • Medtronic plc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Drug Delivery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Drug Delivery Devices Market, South Korea
3.1 Drug Delivery Devices Market, South Korea, Revenue ($m), 2009-2023
3.2 Drug Delivery Devices Market, South Korea, Revenue Mix ($m), 2016
3.3 Drug Delivery Devices Market, South Korea, Category Contribution by Revenue ($m), 2016
3.4 Drug Delivery Devices Market, South Korea, Category Comparison by Revenue ($m), 2009-2023
3.5 Drug Delivery Devices Market, South Korea, Revenue ($m), 2009-2016
3.6 Drug Delivery Devices Market, South Korea, Revenue ($m), 2016-2023
3.7 Drug Delivery Devices Market, South Korea, Volume (Units), 2009-2023
3.8 Drug Delivery Devices Market, South Korea, Volume (Units), 2009-2016
3.9 Drug Delivery Devices Market, South Korea, Volume (Units), 2016-2023
3.10 Drug Delivery Devices Market, South Korea, Company Share by Revenue ($m), 2016
4 Central Venous Catheters Market, South Korea
4.1 Central Venous Catheters Market, South Korea, Revenue Mix ($m), 2016
4.2 Central Venous Catheters Market, South Korea, Segment Contribution (%), 2016
4.3 Central Venous Catheters Market, South Korea, Revenue ($m), 2009-2016
4.4 Central Venous Catheters Market, South Korea, Revenue ($m), 2016-2023
4.5 Central Venous Catheters Market, South Korea, Volume (Units), 2009-2016
4.6 Central Venous Catheters Market, South Korea, Volume (Units), 2016-2023
4.7 Central Venous Catheters Market, South Korea, Distribution Share by Revenue ($m), 2015-2016
4.8 Central Venous Catheters Market, South Korea, Company Share by Revenue ($m), 2016
5 Infusion Systems Market, South Korea
5.1 Infusion Systems Market, South Korea, Revenue Mix ($m), 2016
5.2 Infusion Systems Market, South Korea, Segment Contribution (%), 2016
5.3 Infusion Systems Market, South Korea, Revenue ($m), 2009-2016
5.4 Infusion Systems Market, South Korea, Revenue ($m), 2016-2023
5.4.1 Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), by Segment, 2009-2016
5.4.2 Syringe Pumps Market, South Korea, Revenue ($m), by Segment, 2009-2016
5.4.3 Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), by Segment, 2016-2023
5.4.4 Syringe Pumps Market, South Korea, Revenue ($m), by Segment, 2016-2023
5.5 Infusion Systems Market, South Korea, Volume (Units), 2009-2016
5.6 Infusion Systems Market, South Korea, Volume (Units), 2016-2023
5.6.1 Ambulatory Infusion Pumps Market, South Korea, Volume (Units), by Segment, 2009-2016
5.6.2 Syringe Pumps Market, South Korea, Volume (Units), by Segment, 2009-2016
5.6.3 Ambulatory Infusion Pumps Market, South Korea, Volume (Units), by Segment, 2016-2023
5.6.4 Syringe Pumps Market, South Korea, Volume (Units), by Segment, 2016-2023
5.7 Infusion Systems Market, South Korea, Distribution Share by Revenue ($m), 2015-2016
5.8 Infusion Systems Market, South Korea, Company Share by Revenue ($m), 2016
6 Infusion Systems Market, South Korea
6.1 Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), 2009-2016
6.2 Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), 2016-2023
6.3 Metered Dose Inhaler Devices Market, South Korea, Volume (Units), 2009-2016
6.4 Metered Dose Inhaler Devices Market, South Korea, Volume (Units), 2016-2023
6.5 Metered Dose Inhaler Devices Market, South Korea, Distribution Share by Revenue ($m), 2015-2016
6.6 Metered Dose Inhaler Devices Market, South Korea, Company Share by Revenue ($m), 2016
7 Needle Free Injections Market, South Korea
7.1 Needle Free Injections Market, South Korea, Revenue ($m), 2009-2016
7.2 Needle Free Injections Market, South Korea, Revenue ($m), 2016-2023
7.3 Needle Free Injections Market, South Korea, Volume (Units), 2009-2016
7.4 Needle Free Injections Market, South Korea, Volume (Units), 2016-2023
7.5 Needle Free Injections Market, South Korea, Distribution Share by Revenue ($m), 2015-2016
7.6 Needle Free Injections Market, South Korea, Company Share by Revenue ($m), 2016
8 Overview of Key Companies in South Korea, Drug Delivery Devices Market
8.1 GlaxoSmithKline Plc
8.1.1 Company Overview
8.2 Teleflex Inc
8.2.1 Company Overview
8.3 Edwards Lifesciences Corp
8.3.1 Company Overview
8.4 AstraZeneca Plc
8.4.1 Company Overview
8.5 Fresenius Kabi AG
8.5.1 Company Overview
8.6 Boehringer Ingelheim GmbH
8.6.1 Company Overview
8.7 Pfizer Inc
8.7.1 Company Overview
8.8 Baxter International Inc
8.8.1 Company Overview
8.9 Smiths Medical
8.9.1 Company Overview
8.10 Becton Dickinson and Co
8.10.1 Company Overview
8.11 Merck & Co Inc
8.11.1 Company Overview
8.12 Terumo Corp
8.12.1 Company Overview
8.13 B. Braun Melsungen AG
8.13.1 Company Overview
8.14 Hospira Inc
8.14.1 Company Overview
8.15 JMS Co Ltd
8.15.1 Company Overview
8.16 Medtronic plc
8.16.1 Company Overview
8.17 Nipro Corp
8.17.1 Company Overview
9 Drug Delivery Devices Market Pipeline Products
10 Financial Deals Landscape
10.1 Asset Transactions
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
10.2 Equity Offerings
10.2.1 Curexo to Raise USD9.7 Million in Private Placement of Shares
10.2.2 BCWorld Pharm Raises USD1.8 Million in Private Placement of Shares
10.3 Partnerships
10.3.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
10.3.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
10.3.3 Pfizer Terminates its Licensing Agreement with pSivida
10.3.4 Bayer Enters into Licensing Agreement with DelSiTech
10.3.5 BioCorRx Enters into Licensing Agreement with Therakine
11 Appendix
11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Company Share Analysis
11.1.5 Distribution Share Analysis
11.1.6 Benchmarking
11.2 Consulting
11.3 Contact
11.4 Disclaimer

List of Tables
Table 1: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, 2009-2023
Table 2: Drug Delivery Devices Market, South Korea, Category Contribution by Revenue ($m), 2016
Table 3: Drug Delivery Devices Market, South Korea, Category Comparison by Revenue ($m), 2009-2023
Table 4: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 6: Drug Delivery Devices Market, South Korea, Volume (Units), 2009-2023
Table 7: Drug Delivery Devices Market, South Korea, Volume (Units), Historic, 2009-2016
Table 8: Drug Delivery Devices Market, South Korea, Volume (Units), Forecast, 2016-2023
Table 9: Drug Delivery Devices Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016
Table 10: Central Venous Catheters Market, South Korea, Segment Contribution (%), 2016
Table 11: Central Venous Catheters Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Table 12: Central Venous Catheters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 13: Central Venous Catheters Market, South Korea, Volume (Units), Historic, 2009-2016
Table 14: Central Venous Catheters Market, South Korea, Volume (Units), Forecast, 2016-2023
Table 15: Central Venous Catheters Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Central Venous Catheters Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Infusion Systems Market, South Korea, Segment Contribution (%), 2016
Table 18: Infusion Systems Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Infusion Systems Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 20: Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Table 21: Syringe Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Table 22: Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 23: Syringe Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 24: Infusion Systems Market, South Korea, Volume (Units), Historic, 2009-2016
Table 25: Infusion Systems Market, South Korea, Volume (Units), Forecast, 2016-2023
Table 26: Ambulatory Infusion Pumps Market, South Korea, Volume (Units), Historic, 2009-2016
Table 27: Syringe Pumps Market, South Korea, Volume (Units), Historic, 2009-2016
Table 28: Ambulatory Infusion Pumps Market, South Korea, Volume (Units), Forecast, 2016-2023
Table 29: Syringe Pumps Market, South Korea, Volume (Units), Forecast, 2016-2023
Table 30: Infusion Systems Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 31: Infusion Systems Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Metered Dose Inhaler Devices Market, South Korea, Volume (Units), Historic, 2009-2016
Table 35: Metered Dose Inhaler Devices Market, South Korea, Volume (Units), Forecast, 2016-2023
Table 36: Metered Dose Inhaler Devices Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 37: Metered Dose Inhaler Devices Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016
Table 38: Needle Free Injections Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Needle Free Injections Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Needle Free Injections Market, South Korea, Volume (Units), Historic, 2009-2016
Table 41: Needle Free Injections Market, South Korea, Volume (Units), Forecast, 2016-2023
Table 42: Needle Free Injections Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Needle Free Injections Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Drug Delivery Devices Market Pipeline Products
Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
Table 46: Curexo to Raise USD9.7 Million in Private Placement of Shares
Table 47: BCWorld Pharm Raises USD1.8 Million in Private Placement of Shares
Table 48: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
Table 49: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Table 50: Pfizer Terminates its Licensing Agreement with pSivida
Table 51: Bayer Enters into Licensing Agreement with DelSiTech
Table 52: BioCorRx Enters into Licensing Agreement with Therakine

List of Figures
Figure 1: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, 2009-2023
Figure 2: Drug Delivery Devices Market, South Korea, Revenue Mix ($m), 2016
Figure 3: Drug Delivery Devices Market, South Korea, Category Contribution (%), 2016
Figure 4: Drug Delivery Devices Market, South Korea, Category Comparison by Revenue ($m), 2009-2023
Figure 5: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 7: Drug Delivery Devices Market, South Korea, Volume (Units), 2009-2023
Figure 8: Drug Delivery Devices Market, South Korea, Volume (Units), Historic, 2009-2016
Figure 9: Drug Delivery Devices Market, South Korea, Volume (Units), Forecast, 2016-2023
Figure 10: Drug Delivery Devices Market, South Korea, Company Share (%) 2016
Figure 11: Central Venous Catheters Market, South Korea, Revenue Mix ($m), 2016
Figure 12: Central Venous Catheters Market, South Korea, Segment Contribution (%), 2016
Figure 13: Central Venous Catheters Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Central Venous Catheters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 15: Central Venous Catheters Market, South Korea, Volume (Units), Historic, 2009-2016
Figure 16: Central Venous Catheters Market, South Korea, Volume (Units), Forecast, 2016-2023
Figure 17: Central Venous Catheters Market, South Korea, Company Share (%) 2016
Figure 18: Infusion Systems Market, South Korea, Revenue Mix ($m), 2016
Figure 19: Infusion Systems Market, South Korea, Segment Contribution (%), 2016
Figure 20: Infusion Systems Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Infusion Systems Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 23: Syringe Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 24: Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 25: Syringe Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 26: Infusion Systems Market, South Korea, Volume (Units), Historic, 2009-2016
Figure 27: Infusion Systems Market, South Korea, Volume (Units), Forecast, 2016-2023
Figure 28: Ambulatory Infusion Pumps Market, South Korea, Volume (Units), Historic, 2009-2016
Figure 29: Syringe Pumps Market, South Korea, Volume (Units), Historic, 2009-2016
Figure 30: Ambulatory Infusion Pumps Market, South Korea, Volume (Units), Forecast, 2016-2023
Figure 31: Syringe Pumps Market, South Korea, Volume (Units), Forecast, 2016-2023
Figure 32: Infusion Systems Market, South Korea, Company Share (%) 2016
Figure 33: Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 34: Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 35: Metered Dose Inhaler Devices Market, South Korea, Volume (Units), Historic, 2009-2016
Figure 36: Metered Dose Inhaler Devices Market, South Korea, Volume (Units), Forecast, 2016-2023
Figure 37: Metered Dose Inhaler Devices Market, South Korea, Company Share (%) 2016
Figure 38: Needle Free Injections Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 39: Needle Free Injections Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 40: Needle Free Injections Market, South Korea, Volume (Units), Historic, 2009-2016
Figure 41: Needle Free Injections Market, South Korea, Volume (Units), Forecast, 2016-2023
Figure 42: Needle Free Injections Market, South Korea, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GlaxoSmithKline Plc
  • Teleflex Inc
  • Edwards Lifesciences Corp
  • AstraZeneca Plc
  • Fresenius Kabi AG
  • Boehringer Ingelheim GmbH
  • Pfizer Inc
  • Baxter International Inc
  • Smiths Medical
  • Becton Dickinson and Co
  • Merck & Co Inc
  • Terumo Corp
  • B. Braun Melsungen AG
  • Hospira Inc
  • JMS Co Ltd
  • Medtronic plc
  • Nipro Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll